Profil
Belinda Tsao-Nivaggioli is currently the Chairman & Chief Executive Officer at Avicena Group, Inc. She is also an Independent Director at Fe Pharmaceuticals (Canada), Inc. and a Director at Fe Pharmaceuticals, Inc. Dr. Tsao-Nivaggioli completed her undergraduate degree at Oberlin College and her graduate and doctorate degrees at the University of Toronto.
Postes actifs de Belinda Tsao-Nivaggioli
| Sociétés | Poste | Début |
|---|---|---|
Avicena Group, Inc.
Avicena Group, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and skin care products | Directeur Général | - |
Fe Pharmaceuticals, Inc.
Fe Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in broad spectrum, anti-infective and anti-inflammatory polymer for drug resistant infections, sepsis, inflammation & cancer | Directeur/Membre du Conseil | - |
Fe Pharmaceuticals (Canada), Inc.
Fe Pharmaceuticals (Canada), Inc. Pharmaceuticals: MajorHealth Technology Develops patented iron-binding molecules that remove biologically available iron, making pathogens susceptible to existing antibiotics | Directeur/Membre du Conseil | 01/09/2020 |
Formation de Belinda Tsao-Nivaggioli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Avicena Group, Inc.
Avicena Group, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and skin care products | Health Technology |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fe Pharmaceuticals (Canada), Inc.
Fe Pharmaceuticals (Canada), Inc. Pharmaceuticals: MajorHealth Technology Develops patented iron-binding molecules that remove biologically available iron, making pathogens susceptible to existing antibiotics | Health Technology |
Fe Pharmaceuticals, Inc.
Fe Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in broad spectrum, anti-infective and anti-inflammatory polymer for drug resistant infections, sepsis, inflammation & cancer | Health Technology |
















